Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 15;11(1):8323.
doi: 10.1038/s41598-021-86193-3.

Optimising assessment of dark adaptation data using time to event analysis

Affiliations

Optimising assessment of dark adaptation data using time to event analysis

Bethany E Higgins et al. Sci Rep. .

Abstract

In age-related macular degeneration (AMD) research, dark adaptation has been found to be a promising functional measurement. In more severe cases of AMD, dark adaptation cannot always be recorded within a maximum allowed time for the test (~ 20-30 min). These data are recorded either as censored data-points (data capped at the maximum test time) or as an estimated recovery time based on the trend observed from the data recorded within the maximum recording time. Therefore, dark adaptation data can have unusual attributes that may not be handled by standard statistical techniques. Here we show time-to-event analysis is a more powerful method for analysis of rod-intercept time data in measuring dark adaptation. For example, at 80% power (at α = 0.05) sample sizes were estimated to be 20 and 61 with uncapped (uncensored) and capped (censored) data using a standard t-test; these values improved to 12 and 38 when using the proposed time-to-event analysis. Our method can accommodate both skewed data and censored data points and offers the advantage of significantly reducing sample sizes when planning studies where this functional test is an outcome measure. The latter is important because designing trials and studies more efficiently equates to newer treatments likely being examined more efficiently.

PubMed Disclaimer

Conflict of interest statement

GM, DPC and AMB received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant 116076 (MACUSTAR). This joint undertaking receives support from the European Union’s Horizon 2020 research and innovation program and European Federation of Pharmaceutical Industries and Associations (EFPIA). The communication reflects the authors’ view and that neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein. GM is a consultant for CenterVue and DPC is a consultant for CenterVue and Apellis, has received speaker’s fees from Santen, Allergan and Bayer, and has received compensation as a member of the scientific advisory board of Roche. These affiliations do not directly impact the work in this manuscript. Remaining author BEH declares that they have no conflict of interest.

Figures

Figure 1
Figure 1
Empirical curves for the original (top) and the transformed (bottom) data, scaled to illustrate RITs that surpass a cut off time. The vertical dashed line acts as a marker, representing this capping limit of 20-min. Note that the actual underlying distribution of RIT values is depicted in the figure, so no censoring is shown here. However, the survival model is fitted considering all values beyond 20 min as censored. For the scaled data, both the fitted survival curves from the mode (dashed curves) and the median values (vertical solid lines) were calculated from capped data. However, the time-to-event model fits the data well even beyond the cut off time. For the scaled AMD data, the time-to-event model correctly predicts a median value beyond the capping limit. Figure generated using the ggplot2 package.
Figure 2
Figure 2
Power curves as a function of sample size for the three methods considered with and without capping for the scaled data. The power curves for the original data (not scaled) are identical to the scaled uncapped data and are therefore not reported (10,000 bootstrap simulations for each step in the sample size). Figure generated using the ggplot2 package.
Figure 3
Figure 3
The change in Log10 sensitivity for three control subjects and three patients with AMD is plotted in the top panel (filled dots) with the corresponding Rod Intercept Time values (vertical strokes) provided by the device. The horizontal dashed line represents the 3 log-step change in sensitivity used by the device to define the event (recovery from bleaching). The RIT time for each recovery “event” is used to build the survival curves (bottom panels). In this case, the vertical coloured lines also identify the same RIT values recorded for the curves plotted in the top panels. Notice how each vertical line corresponds to a downward step change in the survival curve (in black). The same process is applied for all RIT values in the dataset to calculate the other step changes that make up the rest of the survival curve. A marker demonstrating the cut off time has been added. Figure generated using the ggplot2 package.

References

    1. Owsley C, McGwin G, Jackson GR, Kallies K, Clark M. Cone- and rod-mediated dark adaptation impairment in age-related maculopathy. Ophthalmology. 2007;114:1728–1735. doi: 10.1016/j.ophtha.2006.12.023. - DOI - PubMed
    1. Owsley C, et al. Comparison of visual function in older eyes in the earliest stages of age-related macular degeneration to those in normal macular health. Curr. Eye Res. 2016;41:266–272. doi: 10.3109/02713683.2015.1011282. - DOI - PMC - PubMed
    1. Owsley C, Clark ME, McGwin G. Natural history of rod-mediated dark adaptation over 2 years in intermediate age-related macular degeneration. Transl. Vis. Sci. Technol. 2017;6:15. doi: 10.1167/tvst.6.3.15. - DOI - PMC - PubMed
    1. Chen C, et al. The local cone and rod system function in early age-related macular degeneration. Documenta Ophthalmologica Adv. Ophthalmol. 2004;109:1–8. doi: 10.1007/s10633-004-1041-0. - DOI - PubMed
    1. Owsley C, et al. Associations between abnormal rod-mediated dark adaptation and health and functioning in older adults with normal macular health. Investig. Ophthalmol. Vis. Sci. 2014;55:4776–4789. doi: 10.1167/iovs.14-14502. - DOI - PMC - PubMed